0

Rheumatoid Arthritis Collection
 1-20 of 214 Articles
Original Research |  20 August 2013
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: A Randomized Trial
Joel Kremer, MD; Zhan-Guo Li, MD, PhD; Stephen Hall, MD; et al.
Ann Intern Med. 2013;159(4):253-261. doi:10.7326/0003-4819-159-4-201308200-00006
Updates |  18 June 2013
Update in Rheumatology: Evidence Published in 2012
Atul Deodhar, MD
Ann Intern Med. 2013;158(12):903-906. doi:10.7326/0003-4819-158-12-201306180-00107
Editorials |  6 March 2012
Combination Therapy Including Glucocorticoids: The New Gold Standard for Early Treatment in Rheumatoid Arthritis?
John Richard Kirwan, MD
Ann Intern Med. 2012;156(5):390-391. doi:10.7326/0003-4819-156-5-201203060-00014
Original Research |  6 March 2012 FREE
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis: A Randomized Trial
Marije F. Bakker, PhD; Johannes W.G. Jacobs, PhD, MD; Paco M.J. Welsing, PhD; et al.
Ann Intern Med. 2012;156(5):329-339. doi:10.7326/0003-4819-156-5-201203060-00004
Reviews |  6 April 2010
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
Penny F. Whiting, PhD; Nynke Smidt, PhD; Jonathan A.C. Sterne, PhD; et al.
Ann Intern Med. 2010;152(7):456-464. doi:10.7326/0003-4819-152-7-201004060-00010
Editorials |  3 November 2009
Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?
Maarten Boers, MSc, MD, PhD
Ann Intern Med. 2009;151(9):668-669. doi:10.7326/0003-4819-151-9-200911030-00013
Articles |  18 August 2009 FREE
Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis: A Randomized Trial
Raphaela Goldbach-Mansky, MD, MHS; Mildred Wilson, RN; Roy Fleischmann, MD; et al.
Ann Intern Med. 2009;151(4):229-240. doi:10.7326/0003-4819-151-4-200908180-00005
Editorials |  15 January 2008 FREE
Comparative Effectiveness of Treatments for Rheumatoid Arthritis
Jeffrey Siegel, MD
Ann Intern Med. 2008;148(2):162-163. doi:10.7326/0003-4819-148-2-200801150-00012
Reviews |  15 January 2008 FREE
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
Katrina E. Donahue, MD, MPH; Gerald Gartlehner, MD, MPH; Daniel E. Jonas, MD, MPH; et al.
Ann Intern Med. 2008;148(2):124-134. doi:10.7326/0003-4819-148-2-200801150-00192
Editorials |  5 June 2007
Anti–Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze
Axel Finckh, MD, MS; Matthew H. Liang, MD, MPH
Ann Intern Med. 2007;146(11):816-817. doi:10.7326/0003-4819-146-11-200706050-00011
Reviews |  5 June 2007
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
Kunihiro Nishimura, MD, MPH, MS; Daisuke Sugiyama, MD, MPH; Yoshinori Kogata, MD; et al.
Ann Intern Med. 2007;146(11):797-808. doi:10.7326/0003-4819-146-11-200706050-00008
Editorials |  20 March 2007
The BeSt Way to Treat Early Rheumatoid Arthritis?
James R. O'Dell, MD
Ann Intern Med. 2007;146(6):459-460. doi:10.7326/0003-4819-146-6-200703200-00014
Articles |  20 March 2007
Comparison of Treatment Strategies in Early Rheumatoid Arthritis: A Randomized Trial
Yvonne P.M. Goekoop-Ruiterman, MD; Jeska K. de Vries-Bouwstra, MD; Cornelia F. Allaart, MD; et al.
Ann Intern Med. 2007;146(6):406-415. doi:10.7326/0003-4819-146-6-200703200-00005
Editorials |  20 June 2006
Abatacept in Rheumatoid Arthritis: A New Branch on the “Biologics” Tree
Maarten Boers, MSc, MD, PhD
Ann Intern Med. 2006;144(12):933-935. doi:10.7326/0003-4819-144-12-200606200-00012
Articles |  20 June 2006
Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis: A Randomized Trial
Joel M. Kremer, MD; Harry K. Genant, MD; Larry W. Moreland, MD; et al.
Ann Intern Med. 2006;144(12):865-876. doi:10.7326/0003-4819-144-12-200606200-00003
Articles |  21 February 2006
Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
Mary J. Roman, MD; Elfi Moeller, AB; Adrienne Davis, AB; et al.
Ann Intern Med. 2006;144(4):249-256. doi:10.7326/0003-4819-144-4-200602210-00006
Articles |  5 November 2002
Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate: A Randomized, Double-Blind, Placebo-Controlled Trial
Joel M. Kremer, MD; Mark C. Genovese, MD; Grant W. Cannon, MD; et al.
Ann Intern Med. 2002;137(9):726-733. doi:10.7326/0003-4819-137-9-200211050-00007
Reviews |  18 June 2002
Rheumatoid Arthritis—A Molecular Understanding
J. Bruce Smith, MD; Mark K. Haynes, PhD
Ann Intern Med. 2002;136(12):908-922. doi:10.7326/0003-4819-136-12-200206180-00012
Therapeutics |  May/Jun 2002
Review: Adding newer disease-modifying drugs or biological agents to methotrexate improved rheumatoid arthritis symptoms
Deborah P.M. Symmons, MD
Ann Intern Med. 2002;136(3):97. doi:10.7326/ACPJC-2002-136-3-097
Editorials |  1 January 2002
Are Long-Term Very Low Doses of Prednisone for Patients with Rheumatoid Arthritis as Helpful as High Doses Are Harmful?
Theodore Pincus, MD; Tuulikki Sokka, MD, PhD; C. Michael Stein, MD
Ann Intern Med. 2002;136(1):76-78. doi:10.7326/0003-4819-136-1-200201010-00013
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)